The Indian Pharmaceuticals industry has witnessed a robust growth over the past few years and is expected to grow to USD 100 billion by 2025. Today, a large number of generics and over-the-counter medicines in the U.S. Russia, Ukraine, Kenya, Kazakhstan, Kyrgyzstan, China are imported, much of it from India. Demand of the Indian made generic across the globe is a testimony of India’s significant role in the global pharmaceutical arena ...
See More About UsDoor delivery of pharmaceutical products in most of the Central Asia and Europe countries.
Key export geographies include Russia, Ukraine, and other CIS countries.
Workforce of more than 30 experts and dedicated in house team.
Strong portfolio of organic and inorganic products
